Carrum Health, a digital marketplace for employers to purchase bundled healthcare services, announced it has partnered with Florida Cancer Specialists & Research Institute to offer employers in Florida breast cancer care services.
Carrum Health offers a value-based platform that allows self-funded employers to buy specialty care, focusing on surgical and cancer care. It provides a digital...
Duopharma Biotech, one of Malaysia's biggest pharmaceutical companies, has committed to expanding access to a mobile breast cancer screening device at the community level.
It has signed a distribution deal with the Malaysian unit of US-based femtech company UE LifeSciences to make the iBreastExam device available in primary care clinics across the country.
iBreastExam is a hand-held, radiation-...
Med-tech company iCAD announced it would incorporate Google Health's mammography AI technology into its breast-imaging solutions thanks to a strategic development and commercialization agreement.
Cancer detection and therapy solutions platform iCAD will utilize Google's AI breast-imaging technology in its portfolio, including its clinical decision support tool for breast cancer risk-estimation...
See-Mode Technologies, a medtech startup based in Melbourne, Australia and Singapore, has received the approval of Health Canada for its software product that supports breast and thyroid ultrasound examinations.
Founded in 2017, the company develops AI to better predict the risk of stroke and vascular diseases by improving the analysis of ultrasound images. Its flagship product, Augmented...
South Korean medical AI company Lunit has become the preferred machine reading solution for BreastScreen NSW's early breast cancer detection programme.
WHAT IT'S ABOUT
BSNSW is part of the national BreastScreen Australia Program which aims to improve the survival rates of women with breast cancer. It offers free mammograms to women aged 40 and above to detect breast cancer early.
A year after...
A cross-sectional study found increased EHR use among primary care physicians was associated with improvement in some quality measures, like diabetes and hypertension control and adherence to breast cancer screening.
The study, published in JAMA Network Open and conducted through Brigham and Women's Hospital and Massachusetts General Hospital in 2021, examined 291 primary care physicians'...
AI startup FathomX from Singapore has raised SG$2.24 million ($1.6 million) from an undisclosed investor in the lead-up to its Series A funding round.
This follows its seed funding round in April last year where it raised SG$500,000 (over $350,000).
WHAT IT DOES
A spin-off from the National University of Singapore and the National University Health System, FathomX offers an AI-powered...
Though breast cancer treatment can be highly effective, women across the globe face drastically different outcomes depending on where they live.
According to research compiled by the World Health Organization, survival for at least five years after diagnosis ranges from more than 90% in high-income countries to only 66% in India and 40% in South Africa.
Geetha Manjunath, founder and CEO of...
Perth-based medical device firm OncoRes Medical has bagged $12.5 million in funding to support its upcoming clinical trials.
It recently scored $9.5 million in a Series A2 funding co-led by VC Brandon Capital and Future of Healthcare Fund by Australian Unity. A separate $3 million funding was secured from the Round 12 grant of the Cooperative Research Centres Projects of AusIndustry, the business...
A smartphone app could improve breast cancer patients’ adherence to multidisciplinary treatment plans, according to a study published in the Journal of Medical Internet Research.
TOP LINE DATA
A total of 4,475 patients who had received a breast cancer diagnosis and had undergone a discussion about multidisciplinary treatment between March 2013 and May 2019 were included in the study.
They were...
